U.S. Residential REITs Stock News

NYSE:STVN
NYSE:STVNLife Sciences

Is Stevanato Group (STVN) Quietly Redefining Its At-Home Biologic Delivery Strategy With New Partnership?

Datwyler recently announced a collaboration with LTS Device Technologies and Stevanato Group to create a pre-verified large-volume subcutaneous drug delivery ecosystem, showcased at Pharmapack in Paris in January 2026. The partnership highlights how Stevanato’s EZ-fill large-volume cartridges can be integrated with advanced plungers and wearable devices to support at-home administration of sensitive therapies. We’ll now explore how this large-volume self-administration platform could...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

Did Big EPS, Revenue Jump and JPM Spotlight Just Shift AnaptysBio's (ANAB) Investment Narrative?

AnaptysBio, Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, where President and CEO Daniel R. Faga outlined the company’s latest corporate and pipeline updates. This appearance comes as AnaptysBio reports very large year-over-year improvements in both earnings per share and revenue, alongside higher analyst earnings forecasts that are reshaping investor expectations. We’ll now examine how this combination of very large profitability gains and a...
NasdaqCM:LPTH
NasdaqCM:LPTHElectronic

Is LightPath (LPTH) Using Its Needham Spotlight to Recast Its High‑Value Solutions Strategy?

LightPath Technologies recently presented at the 28th Annual Needham Growth Conference held at The Lotte New York Palace Hotel in New York, drawing interest from investors and industry observers. This conference appearance matters because investors often watch these sessions for updates on product focus, contract pipelines, and management’s execution priorities. We’ll now examine how LightPath’s Needham Growth Conference presentation might influence its investment narrative, particularly...
NasdaqGS:ALGM
NasdaqGS:ALGMSemiconductor

Allegro MicroSystems (ALGM) Is Up 6.6% After Expanding EV and AI Power-Chip Lineup - What's Changed

In early January 2026, Allegro MicroSystems expanded its Power-Thru™ isolated gate driver family and introduced the ultra‑low‑loss ACS37200 current sensor, targeting efficiency, power density, and noise reduction in EVs, AI data centers, industrial automation, and clean energy systems. By combining integrated isolation, smaller footprints, and lower power loss, these products aim to simplify high-voltage system design and deepen Allegro’s role in next‑generation electrified and data‑centric...
NasdaqGM:EH
NasdaqGM:EHAerospace & Defense

How EHang (EH) Elevating Founding Engineer Shuai Feng to CTO Has Changed Its Investment Story

EHang Holdings Limited has appointed founding team member Shuai Feng as Chief Technology Officer, effective January 14, 2026, formalizing his leadership across pilotless human-carrying eVTOL development, supply chain, and compliance functions. By combining deep product engineering experience with responsibility for procurement, manufacturing scale-up, and safety-focused compliance, Feng’s expanded remit tightly links EHang’s technology roadmap with its commercialization and industrial...
NYSE:CBZ
NYSE:CBZProfessional Services

CBIZ (NYSE:CBZ) Valuation Reset After Share Price Weakness And Marcum Acquisition Integration

Why CBIZ (CBZ) is on investors’ radar CBIZ (CBZ) has drawn attention after a period of softer share performance, including a 40% decline over the past year. This has prompted investors to reassess the stock against its fundamentals and current valuation. See our latest analysis for CBIZ. CBIZ’s 1 day share price return of 1.4% decline and 7 day share price return of 7.23% decline sit against a 1 year total shareholder return of 39.89% decline. This suggests momentum has faded after earlier...
NYSE:VIA
NYSE:VIASoftware

Assessing Via Transportation (VIA) Valuation After Recent Share Price Weakness

Without a single clear news event driving it today, Via Transportation (VIA) has still drawn attention after a sharp share price decline over the past month and the past 3 months, prompting closer scrutiny from investors. See our latest analysis for Via Transportation. At a latest share price of $22.90, Via Transportation’s recent slide includes a 7 day share price return of 10.34%, extending to a 30 day share price return of 31.23% and a 90 day share price return of 52.05%, which suggests...
NasdaqGM:TNGX
NasdaqGM:TNGXBiotechs

Is Tango Therapeutics’ New CEO (TNGX) Quietly Redefining Its Clinical Strategy And Execution Priorities?

Tango Therapeutics recently announced that founding CEO Barbara Weber, M.D., has retired as CEO and President, with board member and oncology veteran Malte Peters, M.D., stepping into the President and CEO roles while Dr. Weber shifts to Executive Chair in 2026 and non-executive Chair in 2027. This leadership reshaping, alongside the addition of experienced biopharma finance executive Sung Lee to the board, signals a concerted focus on clinical execution and corporate development...
NYSE:AN
NYSE:ANSpecialty Retail

What AutoNation (AN)'s Bigger Buyback, Jerry’s Toyota Deal and Q4 Date Mean For Shareholders

AutoNation, Inc. recently announced that it will release its fourth-quarter 2025 financial results, for the period ended December 31, 2025, on February 6, 2026, before the market opens, followed by a management conference call and webcast available via its investor relations website. In parallel, JPMorgan upgraded AutoNation while the company moved to acquire Jerry’s Toyota in Baltimore and expanded its share repurchase authorization by US$1.00 billion to about US$1.28 billion, highlighting...